TrialTransplantation2020

mTOR Inhibitor Therapy Diminishes Circulating CD8+ CD28- Effector Memory T Cells and Improves Allograft Inflammation in Belatacept-refractory Renal Allograft Rejection.

Cyd M Castro-Rojas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.